4
Changes in Ownership
RxSight, Inc. Filed Acc 0001193125-26-386838
Options or other derivatives
- Chief Medical Officer acquired 686,447 shares (grant or award)
- Chief Medical Officer returned 902,819 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
Kurtz Ronald M MD · Chief Medical Officer
Table II: Derivative
8 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-09-05 | Returned to the company : show line 1 in the form Stock option (right to buy) | −338,819 | 0 | D |
| 2026-09-05 | Returned to the company : show line 2 in the form Stock Option (right to buy) | −200,000 | 0 | D |
| 2026-09-05 | Returned to the company : show line 3 in the form Stock Option (right to buy) | −149,000 | 0 | D |
| 2026-09-05 | Returned to the company : show line 4 in the form Stock Option (right to buy) | −215,000 | 0 | D |
| 2026-09-05 | Grant or award : show line 5 in the form Stock Option (right to buy) | +254,751 | 254,751 | D |
| 2026-09-05 | Grant or award : show line 6 in the form Stock Option (right to buy) | +173,913 | 173,913 | D |
| 2026-09-05 | Grant or award : show line 7 in the form Stock Option (right to buy) | +96,129 | 96,129 | D |
| 2026-09-05 | Grant or award : show line 8 in the form Stock Option (right to buy) | +161,654 | 161,654 | D |
Loading xslF345X06/ownership.xml…